Vantrexa · NSCLC · France · Thoracic medical oncologist · captured by Rachel Adeyemi on 07 Feb 2026 · reviewed by Dr. Marcus Lindqvist on 08 Feb 2026
Verbatim as captured; never edited
Thoracic medical oncologist at Hôpital Pitié-Salpêtrière raised elderly / ecog 2 patients during a scientific exchange. They indicated this influences their current prescribing approach.
Human-approved by Dr. Marcus Lindqvist on 08 Feb 2026
Elderly / ECOG 2 patients: gap in current materials reported by thoracic medical oncologist (FR).
No AI assistance
Transparent weighted model; contribution = value ÷ 5 × weight
| Dimension | Value (1–5) | Weight | Contribution |
|---|---|---|---|
| Patient relevance | 4 | 20% | 16.0 |
| Strategic alignment | 3 | 20% | 12.0 |
| Scientific importance | 3 | 15% | 9.0 |
| Urgency | 1 | 15% | 3.0 |
| Novelty | 5 | 10% | 10.0 |
| Actionability | 1 | 10% | 2.0 |
| Confidence | 5 | 5% | 5.0 |
| Breadth of occurrence | 2 | 5% | 2.0 |
| Total | Medium 59 | ||
No audit events in sample data
Every model call on this record and its human outcome
No AI interactions in sample data
Current stage and the next allowed action
Who reviewed, what action, which function, what decision, what outcome, when closed
07 Feb 2026 · Dr. Sven Fischer, Hôpital Pitié-Salpêtrière · MSL Rachel Adeyemi
Insight
Reviewed 08 Feb 2026 by Dr. Marcus Lindqvist
Action
Medical education program · Dr. Sophie Laurent · In progress
Decision
Outcome
Closure
Incorporated into evidence-generation plan.